EUVIMEDEUVIMED entdecken
Open Access

MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells

Varuna Nangia iD, Humza Ashraf, Nasreen Marikar, Victor J Passanisi iD, Christopher R Ill iD, Sabrina L Spencer iD

Science Signaling · 02.09.2025 · 18 (902)

DOI: 10.1126/scisignal.adw3231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, erschienen am 02.09.2025. Verfasst von Varuna Nangia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303, USA. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Cyclin D1, Melanoma, Cell Cycle. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In BRAF -mutant melanoma cells treated with inhibitors of the kinases BRAF and MEK, a subset of cells rapidly and nongenetically adapts to escape drug-induced quiescence and reenters the cell cycle. Here, we investigated the mechanisms enabling this drug escape by computationally reconstructing single-cell lineages from time-lapse imaging data, linking dynamic signaling pathways to distinct cell-cycle fate outcomes. We found that reactivation of the MEK substrate ERK was necessary but not sufficient to drive escape; rather, the activity of the protein complex mTORC1 was also required to promote cell growth and protein synthesis in drug-treated cells destined for cell-cycle reentry. ERK and mTORC1 signaling converged to increase the abundance of cyclin D1 protein, a critical bottleneck for cell-cycle commitment under drug pressure. In cells in which endogenous cyclin D1 was fluorescently tagged using CRISPR, the subset that escaped drug treatment exhibited marked accumulation of cyclin D1 at least 15 hours before cell-cycle reentry, enabling early prediction of future drug escape. Cyclin D1 thus represents both an early biomarker and potential therapeutic target for suppressing drug escape in melanoma. We observed a similar mTORC1-driven mechanism underlying escape in lung cancer cells, but not colon cancer cells, highlighting partial generalizability across cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Cyclin D1MelanomaCell CycleMAP Kinase Signaling SystemHumansCell Line, TumorProto-Oncogene Proteins B-rafSignal TransductionDrug Resistance, Neoplasm

Substanzen

Mechanistic Target of Rapamycin Complex 1Cyclin D1CCND1 protein, humanProto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303, USA.
  • Medical Scientist Training Program, University of Colorado Anschutz Medical School, Aurora, CO 80045, USA.

ORCID-Profile: Varuna Nangia, Victor J Passanisi, Christopher R Ill, Sabrina L Spencer

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Nangia, V., Ashraf, H., Marikar, N., Passanisi, V. J., Ill, C. R., & Spencer, S. L. (2025). MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells. Science Signaling, 18(902). https://doi.org/10.1126/scisignal.adw3231

Vancouver

Nangia V, Ashraf H, Marikar N, Passanisi VJ, Ill CR, Spencer SL. MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells. Science Signaling. 2025;18(902). doi:10.1126/scisignal.adw3231

BibTeX
@article{Nangia2025,
  author = {Nangia, Varuna and Ashraf, Humza and Marikar, Nasreen and Passanisi, Victor J and Ill, Christopher R and Spencer, Sabrina L},
  title = {MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells},
  journal = {Science Signaling},
  year = {2025},
  volume = {18},
  number = {902},
  doi = {10.1126/scisignal.adw3231}
}
Kostenlos starten →